Scale Biosciences Inc. kept two of its genetic-sequencing patents alive as a federal judge rejected Parse Biosciences Inc.’s attempt to invalidate them in a case over single-cell barcoding.
Magistrate Judge Christopher J. Burke rejected Parse’s bid for summary judgment in an order issued Wednesday in the US District Court for the District of Delaware, disposing of the portion of the motion that hadn’t been resolved in an October ruling that invalidated another patent. While denying Parse the early win, the order leaves the validity of claims in US Patent Nos. 10,626,442 and 10,982,256 to be resolved later. Parse argued the ...